NASDAQ •
Healthcare •
Drug Manufacturers - Specialty & Generic •
Quote as of 05/08/2026 16:00
Company Profile
IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeNASDAQ
Market Capitalization425.42 mln
Float49.84 mln
Earnings Date08/05/2026
Piotroski F-Score
2
/ 9
Weak
Beneish M-Score
-2.7
Likely reliable
Relative Strength
94
/ 100
Top performer
Debt / Equity
-5.73
Negative equity
Dividend Yield
0.00%
No dividend
DPS
0.00
No dividend
Business Description
Evolus is a US-based aesthetics company that sells directly to consumers in the United States, Canada, Europe, and Australia. Its main product, Jeuveau, is an injectable treatment that temporarily reduces the appearance of frown lines between the eyebrows. The company also offers Evolysse, a range of injectable fillers designed to restore volume and smooth the appearance of the face, lips, and eyes. Founded in 2012, Evolus operates out of Newport Beach, California.
